Regulation of Hemoglobin β-Chain Synthesis in Bone Marrow Erythroid Cells by α Chains

per Wolf, Jeffrey L., Mason, R. George, Honig, George R.
Publicat 1973

The development of potential antibody-based therapies for myeloma

per Sherbenou, Daniel W., Behrens, Christopher R., Su, Yang, Wolf, Jeffrey L., Martin, Thomas G., Liu, Bin
Publicat a Blood Rev (2014)

DNA methyltransferase inhibitors upregulate CD38 protein expression and enhance daratumumab efficacy in multiple myeloma

per Choudhry, Priya, Mariano, Margarette C., Geng, Huimin, Martin, Thomas G., Wolf, Jeffrey L., Wong, Sandy W., Shah, Nina, Wiita, Arun P.
Publicat a Leukemia (2019)

Tanespimycin with bortezomib: activity in relapsed/refractory patients with multiple myeloma

per Richardson, Paul G., Badros, Ashraf Z., Jagannath, Sundar, Tarantolo, Stefano, Wolf, Jeffrey L., Albitar, Maher, Berman, David, Messina, Marianne, Anderson, Kenneth C.
Publicat 2010

Individualized genetic makeup that controls natural killer cell function influences the efficacy of isatuximab immunotherapy in patients with multiple myeloma

per Sun, Haibo, Martin, Thomas G, Marra, John, Kong, Denice, Keats, Jonathon, Macé, Sandrine, Chiron, Marielle, Wolf, Jeffrey L, Venstrom, Jeffrey M, Rajalingam, Raja
Publicat a J Immunother Cancer (2021)

Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells

per Sherbenou, Daniel W., Aftab, Blake T., Su, Yang, Behrens, Christopher R., Wiita, Arun, Logan, Aaron C., Acosta-Alvear, Diego, Hann, Byron C., Walter, Peter, Shuman, Marc A., Wu, Xiaobo, Atkinson, John P., Wolf, Jeffrey L., Martin, Thomas G., Liu, Bin
Publicat a J Clin Invest (2016)

CRISPR-based screens uncover determinants of immunotherapy response in multiple myeloma

per Ramkumar, Poornima, Abarientos, Anthony B., Tian, Ruilin, Seyler, Meghan, Leong, Jaime T., Chen, Merissa, Choudhry, Priya, Hechler, Torsten, Shah, Nina, Wong, Sandy W., Martin, Thomas G., Wolf, Jeffrey L., Roybal, Kole T., Pahl, Andreas, Taunton, Jack, Wiita, Arun P., Kampmann, Martin
Publicat a Blood Adv (2020)

Phase 1b trial of isatuximab, an anti‐CD38 monoclonal antibody, in combination with carfilzomib as treatment of relapsed/refractory multiple myeloma

per Martin, Thomas G., Shah, Nina, Richter, Joshua, Vesole, David H., Wong, Sandy W., Huang, Chiung‐Yu, Madduri, Deepu, Jagannath, Sundar, Siegel, David S., Biran, Noa, Wolf, Jeffrey L., Parekh, Samir, Cho, Hearn J., Munster, Pamela, Richard, Shambavi, Ziti‐Ljajic, Samira, Chari, Ajai
Publicat a Cancer (2021)

Proteasome inhibitor-induced modulation reveals the spliceosome as a specific therapeutic vulnerability in multiple myeloma

per Huang, Hector H., Ferguson, Ian D., Thornton, Alexis M., Bastola, Prabhakar, Lam, Christine, Lin, Yu-Hsiu T., Choudhry, Priya, Mariano, Margarette C., Marcoulis, Makeba D., Teo, Chin Fen, Malato, Julia, Phojanakong, Paul J., Martin, Thomas G., Wolf, Jeffrey L., Wong, Sandy W., Shah, Nina, Hann, Byron, Brooks, Angela N., Wiita, Arun P.
Publicat a Nat Commun (2020)

A meta-analysis of multiple myeloma risk regions in African and European ancestry populations identifies putatively functional loci

per Rand, Kristin A., Song, Chi, Dean, Eric, Serie, Daniel J., Curtin, Karen, Sheng, Xin, Hu, Donglei, Huff, Carol Ann, Bernal-Mizrachi, Leon, Tomasson, Michael H., Ailawadhi, Sikander, Singhal, Seema, Pawlish, Karen, Peters, Edward S., Bock, Cathryn H., Stram, Alex, Van Den Berg, David J, Edlund, Christopher K., V.Conti, David, Zimmerman, Todd, Hwang, Amie E., Huntsman, Scott, Graff, John, Nooka, Ajay, Kong, Yinfei, Pregja, Silvana L., Berndt, Sonja I., Blot, William J., Carpten, John, Casey, Graham, Chu, Lisa, Diver, W. Ryan, Stevens, Victoria L., Lieber, Michael R., Goodman, Phyllis J., Hennis, Anselm J.M., Hsing, Ann W., Mehta, Jayesh, Kittles, Rick A., Kolb, Suzanne, Klein, Eric A., Leske, Cristina, Murphy, Adam B., Nemesure, Barbara, Neslund-Dudas, Christine, Strom, Sara S., Vij, Ravi, Rybicki, Benjamin A., Stanford, Janet L., Signorello, Lisa B., Witte, John S., Ambrosone, Christine B., Bhatti, Parveen, John, Esther M., Bernstein, Leslie, Zheng, Wei, Olshan, Andrew F., Hu, Jennifer J., Ziegler, Regina G., Nyante, Sarah J., Bandera, Elisa V., Birmann, Brenda M., Ingles, Sue A., Press, Michael F., Atanackovic, Djordje, Glenn, Martha J., Cannon-Albright, Lisa A., Jones, Brandt, Tricot, Guido, Martin, Thomas G., Kumar, Shaji K., Wolf, Jeffrey L., Deming, Sandra L., Rothman, Nathaniel, Brooks-Wilson, Angela R., Rajkumar, S. Vincent, Kolonel, Laurence N., Chanock, Stephen J., Slager, Susan L., Severson, Richard K., Janakiraman, Nalini, Terebelo, Howard R., Brown, Elizabeth E., De Roos, Anneclaire J., Mohrbacher, Ann F., Colditz, Graham A., Giles, Graham G., Spinelli, John J., Chiu, Brian C., Munshi, Nikhil C., Anderson, Kenneth C., Levy, Joan, Zonder, Jeffrey A., Orlowski, Robert Z., Lonial, Sagar, Camp, Nicola J., Vachon, Celine M., Ziv, Elad, Stram, Daniel O., Hazelett, Dennis J., Haiman, Christopher A., Cozen, Wendy
Publicat a Cancer Epidemiol Biomarkers Prev (2016)